Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary artery disease in diabetes (original) (raw)
W.B. Kannel, D.L. McGee, Diabetes and cardiovascular disease: the Framingham study. JAMA 241, 2035–2038 (1979) ArticlePubMedCAS Google Scholar
S.M. Grundy, I.J. Benjamin, G.L. Burke et al., Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100, 1134–1146 (1999) PubMedCAS Google Scholar
C. Gazzaruso, Erectile Dysfunction and Silent Myocardial Ischemia. in Harrison’s Principles of Internal Medicine ed. by D.L. Kasper, E. Braunwald, A.S. Fauci, S.L. Hauser, D.L. Longo, J.L. Jameson, J. Loscalzo, 16th edn (McGraw Hill Medical, New York, NY, 2005)
P. Valensi, E. Cosson, It is not yet the time to stop screening diabetic patients for silent myocardial ischaemia. Diabetes Metab. 36, 91–96 (2010) ArticlePubMedCAS Google Scholar
C. Gazzaruso, A. Coppola, A. Giustina, Erectile dysfunction and coronary artery disease in patients with diabetes. Curr. Diabetes Rev. 7, 143–147 (2011) ArticlePubMed Google Scholar
R.A. Kloner, Assessment of cardiovascular risk in patients with erectile dysfunction: focus on the diabetic patient. Endocrine 23, 125–129 (2004) ArticlePubMedCAS Google Scholar
C. Gazzaruso, S.B. Solerte, A. Pujia, A. Coppola et al., Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with asymptomatic coronary artery disease angiographically proven. A potential protective role for statins and 5-phosphodiesterase inhibitors. J. Am. Coll. Cardiol. 51, 2040–2044 (2008) ArticlePubMed Google Scholar
R.C. Ma, W.Y. So, X. Yang et al., Erectile dysfunction predicts coronary artery disease in type 2 diabetes. J. Am. Coll. Cardiol. 51, 2045–2050 (2008) ArticlePubMed Google Scholar
G.D. Batty, L. Qiang, S. Czernichow et al., On behalf of the ADVANCE Collaborative Group. Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes. J. Am. Coll. Cardiol. 56, 1908–1913 (2010) ArticlePubMed Google Scholar
E. Chiurlia, R. D’Amico, C. Ratti, A.R. Granata, R. Romagnoli, M.G. Modena, Subclinical coronary artery atherosclerosis in patients with erectile dysfunction. J. Am. Coll. Cardiol. 46, 1503–1506 (2005) ArticlePubMed Google Scholar
C. Gazzaruso, S. Giordanetti, E. De Amici et al., Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 110, 22–26 (2004) ArticlePubMed Google Scholar
S. Stern, Symptoms other than chest pain may be important in the diagnosis of “silent ischemia”, or “the sounds of silence”. Circulation 111, e435–e437 (2005) ArticlePubMed Google Scholar
H.L. Lee, R. Ngengwe, P. Jones, F. Tang, J.H. O’Keefe, Erectile dysfunction as a coronary artery disease risk equivalent. J Nucl Cardiol 15, 800–803 (2008) PubMed Google Scholar
American Diabetes Association, Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 21, 1551–1559 (1998) Article Google Scholar
F.J. Wackers, L.H. Young, S.E. Inzucchi et al., Detection of Ischemia in asymptomatic diabetics investigators. Detection of Ischemia in asymptomatic diabetics investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 27, 1954–1961 (2004) ArticlePubMed Google Scholar
R. Scognamiglio, C. Negut, A. Ramondo, A. Tiengo, A. Avogaro, Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J. Am. Coll. Cardiol. 47, 65–71 (2006) ArticlePubMed Google Scholar
C. Gazzaruso, A. Garzaniti, S. Giordanetti et al., Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients: a role for lipoprotein(a) and apolipoprotein(a) polymorphism. Diabetes Care 25, 1418–1424 (2002) ArticlePubMed Google Scholar
C. Gazzaruso, A. Garzaniti, S. Giordanetti, C. Falcone, P. Fratino, Silent coronary artery disease in type 2 diabetes mellitus: the role of lipoprotein(a), homocysteine and apo(a) polymorphism. Cardiovasc. Diabetol. 1, 5 (2002) ArticlePubMed Google Scholar
C. Gazzaruso, A. Coppola, T. Montalcini et al., Screening for asymptomatic coronary artery disease can reduce mortality and morbidity in type 2 diabetic patients. Intern. Emerg. Med. (2011). doi: 10.1007/s11739-011-0527-5
C. Gazzaruso, A. Pujia, S.B. Solerte et al., Erectile dysfunction and angiographic extent of coronary artery disease in type II diabetic patients. Int. J. Impot. Res. 18, 311–315 (2006) ArticlePubMedCAS Google Scholar
W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502 (1972) PubMedCAS Google Scholar
R.C. Rosen, J.C. Cappelleri, M.D. Smith, J. Lipsky, B.M. Pena, Development and evaluation of an abridged, 5-item version of the international index of erectile function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int. J. Impot. Res. 11, 319–326 (1999) ArticlePubMedCAS Google Scholar
K. Saltiki, G. Papageorgiou, P. Voidonikola et al., Endogenous estrogen levels are associated with endothelial function in males independently of lipid levels. Endocrine 37, 329–335 (2010) ArticlePubMedCAS Google Scholar
L.H. Young, F.J. Wackers, D.A. Chyun et al., DIAD Investigators. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes. The DIAD study: a randomized controlled trial. JAMA 301, 1547–1555 (2009) ArticlePubMedCAS Google Scholar
P. Sorajja, P. Chareonthaitawee, N. Rajagopalan et al., Improved survival in asymptomatic diabetic patients with high-risk spect imaging treated with coronary artery bypass grafting. Circulation 112, I311–I316 (2005) PubMed Google Scholar
E. Faglia, M. Mantero, A. Quarantiello et al., Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular risk: an open-label randomized pilot study. Am. Heart J. 149, e1–e6 (2005) ArticlePubMed Google Scholar
E. Faglia, F. Favales, P. Calia et al., Cardiac events in 735 type 2 diabetic patients who underwent screening for unknown asymptomatic coronary artery disease. 5-years follow-up report from the Milan study on atherosclerosis and diabetes (MiSAD). Diabetes Care 25, 2032–2036 (2002) ArticlePubMed Google Scholar
E.K. Choi, B.K. Koo, H.S. Kim et al., Prognostic significance of asymptomatic coronary artery disease in patients with diabetes and need for early revascularization therapy. Diabetic Med. 24, 1003–1011 (2007) ArticlePubMedCAS Google Scholar
B.R. Chaitman, R.M. Hardison, D. Adler et al., Bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) study group. The bypass angioplasty revascularization investigation 2 diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction. Circulation 120, 2529–2540 (2009) ArticlePubMedCAS Google Scholar
G.R. Dagenais, J. Lu, D.P. Faxon et al., Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularization in patients with type 2 diabetes mellitus and stable ischemic heart disease. Circulation 123, 1492–1500 (2011) ArticlePubMed Google Scholar
J.H. Martin, S. Mangiafico, D.J. Kelly, Role of statins in diabetes complications. Curr. Diabetes Rev. 5, 165–170 (2009) ArticlePubMedCAS Google Scholar
J.B. Kostis, G. Jackson, R. Rosen et al., Sexual dysfunction and cardiac risk (the second Princeton consensus conference). Am. J. Cardiol. 96, 85M–93M (2005) ArticlePubMed Google Scholar
G. Jackson, N. Boon, I. Eardley et al., Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus. Int. J. Clin. Pract. 64, 848–857 (2010) ArticlePubMedCAS Google Scholar
P. Valensi, J. Paries, V.T. Brulport-Cerisier et al., Predictive value of silent myocardial ischemia for cardiac events in diabetic patients. Influence of age in a French multicenter study. Diabetes Care 28, 2722–2727 (2005) ArticlePubMed Google Scholar
A. Chico, A. Tomas, A. Novials, Silent myocardial ischemia is associated with autonomic neuropathy and other cardiovascular risk factors in type 1 and type 2 diabetic subjects, especially in those with microalbuminuria. Endocrine 27, 213–217 (2005) ArticlePubMedCAS Google Scholar
D.C. Burgess, D. Hunt, L.P. Li, D. Zannino et al., Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the fenifibrate intervention and event lowering in diabetes (FIELD) study. Eur. Heart J. 31, 92–99 (2010) ArticlePubMed Google Scholar
C. Gazzaruso, S.B. Solerte, E. De Amici et al., Association of the metabolic syndrome and insulin-resistance with silent myovcardial ischemia in patients with type 2 diabetes mellitus. Am. J. Cardiol. 97, 236–239 (2006) ArticlePubMedCAS Google Scholar
J.J. Bax, L.H. Young, R.L. Frye, R.O. Bonow, H.O. Steinberg, E.J. Barrett, for the American Diabetes Association, Screening for coronary artery disease in patients with diabetes. Diabetes Care 30, 2729–2736 (2007) ArticlePubMed Google Scholar